anyone's doing RNA-seq with paired-end reads now? how to use pairing information is a challenge. any good ideas?
Unconfigured Ad
Collapse
X
-
Yes. We've done paired end RNAseq - partly because of mixed sample type (some DNAseq etc) flow cells.
The paired end info is useful for novel gene expression and splice junction discovery.
For simple RPKM etc we just treated each read as single end and aligned to genome+splice junctions seperately - this is likely to be suboptimal although easy approach. I'd be very interested in people's comments...
david
-
Rna-pet
Paired-end ditags (PET) is an interesting strategy. It is very economical way of finding splice junction variants. Of course it doesn't offer the same resolution as full paired end RNA-Seq. I believe the team at GIS have migrated to Illumina and SOLiD in particular for RNA-PET now.
Comment
-
Hi all, We have had success with PE RNAseq (illumina).
Some of the main pitfalls that we found:
-when you make your cDNA, if you use random hexamers (best results for us), your first strand synthesis reaction will tend to produce sequences that start/end in GC rich sequences. We have found that these tend to be non-accurate annealling products, and you can improve your mapping efficiency by stripping the first/last few bases.
- TopHAT (see bowtie/ben langmeads posts) has also been very useful (and extremely fast for mapping!!
- Creating 'spliced' reference genomes is very useful for retaining the benefits of PE mapping, without having to introduce huge 'insert' sizes...
- Avoid PET tags - the extra ligation steps, if you are not careful, can introduce a high percentage of 'false' splice events... With the illumina PE strategy there is no need for this...
Has anyone had any luck with barcoding RNAseq samples?
Ieuan
Comment
-
Originally posted by ieuanclay View PostHi all, We have had success with PE RNAseq (illumina).
Some of the main pitfalls that we found:
-when you make your cDNA, if you use random hexamers (best results for us), your first strand synthesis reaction will tend to produce sequences that start/end in GC rich sequences. We have found that these tend to be non-accurate annealling products, and you can improve your mapping efficiency by stripping the first/last few bases.
- TopHAT (see bowtie/ben langmeads posts) has also been very useful (and extremely fast for mapping!!
- Creating 'spliced' reference genomes is very useful for retaining the benefits of PE mapping, without having to introduce huge 'insert' sizes...
- Avoid PET tags - the extra ligation steps, if you are not careful, can introduce a high percentage of 'false' splice events... With the illumina PE strategy there is no need for this...
Has anyone had any luck with barcoding RNAseq samples?
Ieuan
Hi Ieuan,
It is interesting to see PE RNAseq.
I still ahve some doubts regarding mapping PE reads. Because ELAND can support eland_rna analysis for SR(single read) only.
Any tool to map tags with splice juction or can you please explain about the mapping part of PE RNA seq tags?
Thanks.
Comment
-
Check the forums here for TopHat if you want to know about mapping RNAseq!
The actual way that you map is very dependent on the source of your RNA, so i would need to know more about your experiments! My main experience is with nascent RNA, so we PE map againstt a genomic reference. Spliced RNA can be mapped against spliced genomes (again see TopHat). Or a combination of both can be used, i.e. mapping against the genomic reference using a sensible PE insert limit, to find nascent RNA, then mapping the reads that don't map to the reference genome against a spliced genome. This way you can flag potentially spliced and unspliced transcripts.
There really are too many ways of proceeding, you just have to pick a processing pipeline that makes sense for your material/experiment and that you can justify when it comes to publishing.
Hope this helps!?
Comment
-
hai ....I would like to know is it possible to use Bowtie to map the reads which does not have its genome sequenced?
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment